Journal
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Volume 1861, Issue 6, Pages 1515-1520Publisher
ELSEVIER
DOI: 10.1016/j.bbagen.2016.12.020
Keywords
Glioblastoma; Iron oxide nanoparticle; MRI contrast agent; cRGD; Targeting
Categories
Ask authors/readers for more resources
In this article, a specific targeting Magnetic Resonance Imaging (MRI) nanoplatform, composed by iron oxide nanoparticle (NP) with cRGD peptides as targeting agent onto NP surface, is explored for the diagnosis of brain tumors by MRI using intracranial U87MG mice xenograft tumor. This article is part of a Special Issue entitled Recent Advances in Bionanomaterials Guest Editor: Dr. Marie-Louise Saboungi and Dr. Samuel D. Bader. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available